CytoDyn Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CytoDyn Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2019 to Q3 2024.
  • CytoDyn Inc. Operating Lease, Right-of-Use Asset for the quarter ending August 31, 2024 was $230K, a 37.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $230K -$136K -37.2% Aug 31, 2024 10-Q 2024-10-15
Q2 2024 $264K -$136K -34% May 31, 2024 10-Q 2024-10-15
Q1 2024 $298K -$136K -31.3% Feb 29, 2024 10-Q 2024-04-15
Q4 2023 $332K -$136K -29.1% Nov 30, 2023 10-Q 2024-01-16
Q3 2023 $366K -$136K -27.1% Aug 31, 2023 10-Q 2023-10-23
Q2 2023 $400K -$136K -25.4% May 31, 2023 10-K 2024-08-15
Q1 2023 $434K -$136K -23.9% Feb 28, 2023 10-Q 2023-04-10
Q4 2022 $468K -$149K -24.1% Nov 30, 2022 10-Q 2023-01-09
Q3 2022 $502K -$163K -24.5% Aug 31, 2022 10-Q/A 2022-10-13
Q2 2022 $536K -$176K -24.7% May 31, 2022 10-K 2023-09-14
Q1 2022 $570K -$190K -25% Feb 28, 2022 10-Q 2022-04-11
Q4 2021 $617K +$226K +57.8% Nov 30, 2021 10-Q 2022-01-10
Q3 2021 $665K +$245K +58.3% Aug 31, 2021 10-Q 2021-10-12
Q2 2021 $712K +$536K +305% May 31, 2021 10-K 2022-08-15
Q1 2021 $760K +$555K +270% Feb 28, 2021 10-Q 2021-04-14
Q4 2020 $391K +$206K +112% Nov 30, 2020 10-Q 2021-01-08
Q3 2020 $420K +$212K +102% Aug 31, 2020 10-Q 2020-10-09
Q2 2020 $176K +$176K May 31, 2020 10-K 2021-07-30
Q1 2020 $205K Feb 29, 2020 10-Q 2020-04-09
Q4 2019 $185K Nov 30, 2019 10-Q 2020-01-09
Q3 2019 $208K Aug 31, 2019 10-Q 2019-10-08
Q2 2019 $0 May 31, 2019 10-Q 2020-04-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.